Research & Literature
Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.
Top Authors
Top Institutions
Finding nearby institutions...
Children's Hospital of Philadelphia
Philadelphia, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, United States
Boston Children's Hospital
Boston, United States
Sichuan University
Chengdu, China
Gifu University
Gifu, Japan
The University of Texas Southwestern Medical Center
Dallas, United States
Tohoku University
Sendai, Japan
Keio University
Tokyo, Japan
Tokyo Metropolitan Children's Medical Center
Tokyo, Japan
Johns Hopkins University
Baltimore, United States
References
References (49)
- 1
Clinical Features and Prognosis of Generalized Lymphatic Anomaly, Kaposiform Lymphangiomatosis, and Gorham-Stout Disease.
Ozeki M, Fujino A, Matsuoka K, et al.
Pediatric blood & cancer 2016; (63(5)):832-8 doi:10.1002/pbc.25914.
PMID: 26806875 - 2
Imaging features of kaposiform lymphangiomatosis.
Goyal P, Alomari AI, Kozakewich HP, et al.
Pediatric radiology 2016; (46(9)):1282-90 doi:10.1007/s00247-016-3611-1.
PMID: 27053281 - 3
Angiopoietins as serum biomarkers for lymphatic anomalies.
Le Cras TD, Mobberley-Schuman PS, Broering M, et al.
Angiogenesis 2017; (20(1)):163-173 doi:10.1007/s10456-016-9537-2.
PMID: 27990590 - 4
What echocardiographic findings suggest a pericardial effusion is causing tamponade?
Alerhand S, Carter JM
The American journal of emergency medicine 2019; (37(2)):321-326 doi:10.1016/j.ajem.2018.11.004.
PMID: 30471929 - 5
A somatic activating NRAS variant associated with kaposiform lymphangiomatosis.
Barclay SF, Inman KW, Luks VL, et al.
Genetics in medicine : official journal of the American College of Medical Genetics 2019; (21(7)):1517-1524 doi:10.1038/s41436-018-0390-0.
PMID: 30542204 - 6
Somatic activating mutations in PIK3CA cause generalized lymphatic anomaly.
Rodriguez-Laguna L, Agra N, Ibañez K, et al.
The Journal of experimental medicine 2019; (216(2)):407-418 doi:10.1084/jem.20181353.
PMID: 30591517 - 7
Efficacy of systemic sirolimus in the treatment of generalized lymphatic anomaly and Gorham-Stout disease.
Ricci KW, Hammill AM, Mobberley-Schuman P, et al.
Pediatric blood & cancer 2019; (66(5)):e27614 doi:10.1002/pbc.27614.
PMID: 30672136 - 8
Efficacy and safety of sirolimus treatment for intractable lymphatic anomalies: A study protocol for an open-label, single-arm, multicenter, prospective study (SILA).
Ozeki M, Asada R, Saito AM, et al.
Regenerative therapy 2019; (10()):84-91 doi:10.1016/j.reth.2018.12.001.
PMID: 30705924 - 9
The impact of sirolimus therapy on lesion size, clinical symptoms, and quality of life of patients with lymphatic anomalies.
Ozeki M, Nozawa A, Yasue S, et al.
Orphanet journal of rare diseases 2019; (14(1)):141 doi:10.1186/s13023-019-1118-1.
PMID: 31196128 - 10
Potential biomarkers of kaposiform lymphangiomatosis.
Ozeki M, Nozawa A, Kawamoto N, et al.
Pediatric blood & cancer 2019; (66(9)):e27878 doi:10.1002/pbc.27878.
PMID: 31207041 - 11
Kaposiform lymphangiomatosis and kaposiform hemangioendothelioma: similarities and differences.
Ji Y, Chen S, Peng S, et al.
Orphanet journal of rare diseases 2019; (14(1)):165 doi:10.1186/s13023-019-1147-9.
PMID: 31277673 - 12
Detection of NRAS mutation in cell-free DNA biological fluids from patients with kaposiform lymphangiomatosis.
Ozeki M, Aoki Y, Nozawa A, et al.
Orphanet journal of rare diseases 2019; (14(1)):215 doi:10.1186/s13023-019-1191-5.
PMID: 31511039 - 13
Multidisciplinary guidelines for initial evaluation of complicated lymphatic anomalies-expert opinion consensus.
Iacobas I, Adams DM, Pimpalwar S, et al.
Pediatric blood & cancer 2020; (67(1)):e28036 doi:10.1002/pbc.28036.
PMID: 31617676 - 14
[Clinical characteristics of Kaposiform lymphangiomatosis: a report of 8 cases].
Qiu T, Yang KY, Peng SH, et al.
Zhonghua wai ke za zhi [Chinese journal of surgery] 2019; (57(12)):921-926 doi:10.3760/cma.j.issn.0529-5815.2019.12.010.
PMID: 31826597 - 15
Kaposiform lymphangiomatosis treated with multimodal therapy improves coagulopathy and reduces blood angiopoietin-2 levels.
Crane J, Manfredo J, Boscolo E, et al.
Pediatric blood & cancer 2020; (67(9)):e28529 doi:10.1002/pbc.28529.
PMID: 32634277 - 16
Thoracic duct embolization in kaposiform lymphangiomatosis.
Bundy JJ, Ootaki Y, McLean TW, et al.
Journal of vascular surgery. Venous and lymphatic disorders 2020; (8(5)):864-868 doi:10.1016/j.jvsv.2020.03.013.
PMID: 32653407 - 17
Sirolimus in the treatment of kaposiform lymphangiomatosis.
Zhou J, Yang K, Chen S, Ji Y
Orphanet journal of rare diseases 2021; (16(1)):260 doi:10.1186/s13023-021-01893-3.
PMID: 34103076 - 18
Cardiotoxicity in metastatic melanoma patients treated with BRAF and MEK inhibitors in a real-world setting.
Pedersen S, Larsen KO, Christensen AH, et al.
Acta oncologica (Stockholm, Sweden) 2022; (61(1)):45-51 doi:10.1080/0284186X.2021.1992010.
PMID: 34666597 - 19
Cellular variant of kaposiform lymphangiomatosis: a report of three cases, expanding the morphologic and molecular genetic spectrum of this rare entity.
Allen-Rhoades W, Al-Ibraheemi A, Kohorst M, et al.
Human pathology 2022; (122()):72-81 doi:10.1016/j.humpath.2022.02.010.
PMID: 35202617 - 20
Kaposiform lymphangiomatosis presenting with a Group A Streptococcus pericardial effusion.
Koerner T, Patel MD, Pai V, Indramohan G
BMJ case reports 2022; (15(3)) doi:10.1136/bcr-2021-246250.
PMID: 35232734 - 21
Treatment of severe Kaposiform lymphangiomatosis positive for NRAS mutation by MEK inhibition.
Chowers G, Abebe-Campino G, Golan H, et al.
Pediatric research 2023; (94(6)):1911-1915 doi:10.1038/s41390-022-01986-0.
PMID: 35246606 - 22
Kaposiform Lymphangiomatosis: Pathologic Aspects in 43 Patients.
Perez-Atayde AR, Debelenko L, Al-Ibraheemi A, et al.
The American journal of surgical pathology 2022; (46(7)):963-976 doi:10.1097/PAS.0000000000001898.
PMID: 35385405 - 23
Pericardial tamponade: A comprehensive emergency medicine and echocardiography review.
Alerhand S, Adrian RJ, Long B, Avila J
The American journal of emergency medicine 2022; (58()):159-174 doi:10.1016/j.ajem.2022.05.001.
PMID: 35696801 - 24
Recurrent haemoptysis: a rare diagnosis of kaposiform lymphangiomatosis and review of literature.
Fedidat R, Elia A, Hershko A, Fridlender Z
BMJ case reports 2022; (15(9)) doi:10.1136/bcr-2022-250825.
PMID: 36171013 - 25
[Complicated lymphatic anomaly: a clinicopathological analysis of four cases].
Pan BJ, Zhao DC, Zhou WX, Feng RE
Zhonghua bing li xue za zhi = Chinese journal of pathology 2022; (51(11)):1147-1151 doi:10.3760/cma.j.cn112151-20220825-00728.
PMID: 36323545 - 26
Association of bilateral pan-uveitis with the use of trametinib for Langerhans cell histiocytosis.
Du Y, Hu YT
American journal of translational research 2022; (14(12)):8768-8772.
PMID: 36628254 - 27
Kaposiform lymphangiomatosis: Diagnosis, pathogenesis, and treatment.
McDaniel CG, Adams DM, Steele KE, et al.
Pediatric blood & cancer 2023; (70(4)):e30219 doi:10.1002/pbc.30219.
PMID: 36683202 - 28
Kaposiform Lymphangiomatosis in a Male Adolescent: A Clinical Challenge and the Role of Genetics.
Pereira-Nunes J, Madureira M, Dinis A, et al.
Journal of investigative medicine high impact case reports 2023; (11()):23247096231166678 doi:10.1177/23247096231166678.
PMID: 37148180 - 29
How we use angiopoietin-2 in the diagnosis and management of vascular anomalies.
Engel ER, Le Cras TD, Ricci KW
Pediatric blood & cancer 2024; (71(5)):e30921 doi:10.1002/pbc.30921.
PMID: 38439088 - 30
Trametinib inhibits lymphatic vessel invasion of bone in a mouse model of Gorham-Stout disease.
McCarter AL, Dellinger MT
Journal of vascular anomalies 2023; (4(4)) doi:10.1097/jova.0000000000000070.
PMID: 38737531 - 31
Lyve1-Driven NrasQ61R Causes Edema, Enlarged Lymphatic Vessels, and Hepatic Vascular Defects in Embryonic Mice.
McDaniel CG, Fox D, Pastura P, et al.
Pediatric blood & cancer 2025; (72(3)):e31492 doi:10.1002/pbc.31492.
PMID: 39723841 - 32
Primary splenic involvement in kaposiform lymphangiomatosis: A case report.
Covil E, Gates R
International journal of surgery case reports 2025; (127()):110868 doi:10.1016/j.ijscr.2025.110868.
PMID: 39842283 - 33
Complex lymphatic anomalies.
Alkhulaifat D, Ramirez-Suarez KI, Otero HJ, et al.
Pediatric radiology 2025; (55(11)):2348-2355 doi:10.1007/s00247-025-06167-9.
PMID: 39853393 - 34
Perioperative Considerations for a Patient with Juvenile Idiopathic Scoliosis and Kaposiform Lymphangiomatosis Undergoing Spinal Fusion: A Case Report.
Avendano JP, Rauf R, Vickers B, et al.
Journal of orthopaedic case reports 2025; (15(5)):103-108 doi:10.13107/jocr.2025.v15.i05.5572.
PMID: 40351635 - 35
Updated Classification of Vascular Anomalies. A living document from the International Society for the Study of Vascular Anomalies Classification Group.
Goldenberg DC, Vikkula M, Penington A, et al.
Journal of vascular anomalies 2025; (6(2)) doi:10.1097/JOVA.0000000000000113.
PMID: 40636925 - 36
Human Lymphatic Endothelial Cells Expressing NRASQ61R Model Characteristics of Kaposiform Lymphangiomatosis.
Fox DA, McDaniel CG, Pastura P, Le Cras TD
Pediatric blood & cancer 2025; (72(11)):e31984 doi:10.1002/pbc.31984.
PMID: 40879319 - 37
Efficacy and Safety of Trametinib Therapy for Complex Lymphatic Malformations.
Xu Y, Zhou J, Lan Y, Ji Y
Pediatric blood & cancer 2026; (73(1)):e32119 doi:10.1002/pbc.32119.
PMID: 41116710 - 38
Hemopericardium Following Norovirus Gastroenteritis in a Child: An Uncommon Presentation.
Hamed M, Karuppaswamy V
Cureus 2025; (17(10)):e93767 doi:10.7759/cureus.93767.
PMID: 41189868 - 39
Complex Lymphatic Anomalies: A Comprehensive Review of Imaging Features and Diagnostic Considerations.
Pratt M, Dillenbeck J, Pimpalwar S, et al.
Seminars in roentgenology 2026; (62()):150967 doi:10.1016/j.ro.2025.150967.
PMID: 41349185 - 40
MEK Inhibition Reduces Vascular Malformations and Gene Dysregulation in NRASQ61R Human Endothelial Cells.
Alharbi S, Wagner A, Merkle S, et al.
Pediatric blood & cancer 2026; (73(3)):e70002 doi:10.1002/1545-5017.70002.
PMID: 41496696 - 41
Trametinib normalizes angiopoietin-2 levels and successfully treats kaposiform lymphangiomatosis.
McDaniel CG, Merkle S, Lacuna S, et al.
Journal of vascular anomalies 2025; (6(4)) doi:10.1097/jova.0000000000000124.
PMID: 41788185 - 42
Imaging of complex lymphatic anomalies in children.
Klein WM, Biko DM, Gerwins P, Petit P
Pediatric radiology 2026; doi:10.1007/s00247-026-06608-z.
PMID: 42024244 - 43
Kaposiform vascular tumors with Kasabach-Merritt phenomenon: a case series of KHE and KLA from a tertiary care center in India.
Swaminathan VV, Ramasamy A, Veerachamy A, et al.
European journal of pediatrics 2026; (185(5)).
PMID: 42033477 - 44
Kaposiform lymphangiomatosis-the effects of long-term treatment with sirolimus: case series study and review of the literature.
Bilny-Paluch M, Piekarczyk P, Błasińska K, et al.
Frontiers in medicine 2026; (13()):1705297 doi:10.3389/fmed.2026.1705297.
PMID: 42110416 - 45
Long-term low-dose sirolimus therapy and successful discontinuation in an adult with kaposiform lymphangiomatosis and disseminated intravascular coagulation: a case report.
Liu J, Xu W, Jiang Q, Xu KF
Frontiers in medicine 2026; (13()):1852990 doi:10.3389/fmed.2026.1852990.
PMID: 42266937 - 46
NRAS mutation in a central conducting lymphatic anomaly and PPFIBP1::ROS1 fusion in a Gorham-stout disease patient.
Yang G, Ren H, Wang J, et al.
Human molecular genetics 2026; (35(16)) doi:10.1093/hmg/ddag070.
PMID: 42544506 - 47
Interventional embolization for hemorrhagic pleural effusion in an infant with kaposiform lymphangiomatosis: a case report.
Li J, Wang R, Liu C, Liu L
Frontiers in medicine 2026; (13()):1865353 doi:10.3389/fmed.2026.1865353.
PMID: 42597147 - 48
Resolution of Refractory Chylous Effusions With Targeted MEK Inhibition in NRAS Q61R-Driven Kaposiform Lymphangiomatosis: A Case Report.
Brown G, McNab S, Keogh S, et al.
Case reports in pediatrics 2026; (2026()):7037459 doi:10.1155/crpe/7037459.
PMID: 42639465 - 49
Real-life efficacy and tolerance of trametinib in BRAF-rearranged low-grade gliomas: A multicenter study.
Khouri C, Bibollet A, Bouchoucha Y, et al.
European journal of cancer (Oxford, England : 1990) 2026; (248()):117450 doi:10.1016/j.ejca.2026.117450.
PMID: 42858621